| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739740 | Journal of Clinical Virology | 2018 | 4 Pages |
Abstract
Clinical VZV reactivation boosted VZV antibody levels and the level of boosting was dependent upon baseline viral replication. While antibody titres could discriminate patients with shingles 1-6 months earlier from blood donor controls, there was a large trade-off between sensitivity and specificity.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Charlotte Warren-Gash, Harriet Forbes, Peter Maple, Mark Quinlivan, Judith Breuer,